Many studies have suggested that dysregulation of the 5-HT system is associated with neuropsychiatric and neurodevelopmental disorders, such as anxiety and depression, and 5-HTT is a major target for antidepressants and anxiolytics [2–5]. This evidence concerns the gene HTT and major depressive disorder.